‹ All episodes

OIS Podcast | Ophthalmology's leading Podcast

New CEO Mattessich Brings in New Skills, Leadership to Help Ocular Therapeutix Reach Potential

February 07, 2018 OIS
OIS Podcast | Ophthalmology's leading Podcast
New CEO Mattessich Brings in New Skills, Leadership to Help Ocular Therapeutix Reach Potential
Info
OIS Podcast | Ophthalmology's leading Podcast
New CEO Mattessich Brings in New Skills, Leadership to Help Ocular Therapeutix Reach Potential
Feb 07, 2018
OIS
New CEO Antony Mattessich says Ocular Therapeutix has learned its mistakes after receiving two CRLs from the FDA. With new leadership and a clear vision, the company is ready to push forward as a full-fledged biopharmaceutical company.
Share
Apple Podcasts Spotify Amazon Music Overcast iHeartRadio Castro +
Show Notes
New CEO Antony Mattessich says Ocular Therapeutix has learned its mistakes after receiving two CRLs from the FDA. With new leadership and a clear vision, the company is ready to push forward as a full-fledged biopharmaceutical company.